Carlo Incerti - Profile and Investment Details

Investor Profile

Carlo Incerti is a Venture Capital, Private Equity Firm, Investment Partner based in Bussum, North Holland, The Netherlands with a diverse investment portfolio that includes companies such as Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems, Borean Pharma, Roche Glycart, NovoGI, Oxyrane UK, OMEICOS Therapeutics, MolMed, Inflazome, Amakem, Pulmologix, SynOx Therapeutics, Ardana Bioscience, CoviCept Therapeutics, RigontecFlowMedica, Oxular, NeRRe Therapeutics, Hookipa Pharma, NorthSea Therapeutics, SANIFIT, AZAFAROS B.V., EuropaBio - the European Association for Bioindustries, PneumRx, Gotham Therapeutics, Catalym, Insmed, Mitralign, Prilenia, KaNDy Therapeutics, Ario Pharma, Numab Therapeutics AG, Cardoz, CircuLite, BioVex, Cytheris, Bluebird Bio, Pieris AG, UniQure, VectorY, CellNovo, Akarna Therapeutics, Escalier Biosciences, Azafaros, Enterprise Therapeutics, Bioceros, Replimune Group, Exosome Diagnostics, Acorda Therapeutics, Dyne Therapeutics, gIcare Pharma, Amphista Therapeutics, Innovative Medicines Initiative (IMI), Milestone Pharmaceuticals, Dezima Pharma, Fovea Pharmaceuticals, Inversago Pharma, Gyroscope Therapeutics, New Amsterdam Pharma, Autonomic Technologies, Xention, Achilles Therapeutics, EryDel S.p.A., Sparrow Pharmaceuticals, Inc., arGEN-X, Curetis, ACADIA Pharmaceuticals, Allecra Therapeutics, PanGenetics, Promedior, Transave, Argos Therapeutics, enGene, Prexton Therapeutics, . Over time, Carlo Incerti has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Carlo Incerti is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Regenerative Medicine, Genetics, Autoimmune Diseases, Wellness, Immunotherapy, Rare Diseases, Investment Management, Healthcare Innovation, Strategic Partnerships, Life Science, Portfolio Management, Medical Technologies, Finance, Bioinformatics, Biotechnology, Medical Devices, Drug Development, Genomics, Precision Medicine, Environmental Technology, Neuropsychiatric Disorders, Clinical Trials, Capital Raising, Gene Therapy, Health Diagnostics, Regulatory Compliance, Renewable Energy, Medical, Information Technology, B2B, Real Estate, Therapeutics, Cellular Therapy, Media and Entertainment, Pharmaceuticals, Oncology may find it worthwhile to explore potential connections with Carlo Incerti, as their portfolio suggests a familiarity and interest in this area.

Understanding Carlo Incerti’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.